Reply to: Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Addressing Statistical and Methodological Concerns in Survival Analysis

J Clin Oncol. 2025 Jan 9:JCO2402598. doi: 10.1200/JCO-24-02598. Online ahead of print.
No abstract available